Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03191916 · ClinicalTrials.gov registry record · NA

Transcranial Direct Current Stimulation for Cognitive Improvement in Parkinson's Patients

A NA study of Parkinson Disease, sponsored by Sanford Health.

Active
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT03191916 is a NA study of Parkinson Disease that is active but no longer recruiting, run by Sanford Health. The registered enrollment target is 40 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03191916, a NA study of Parkinson Disease, is active but no longer recruiting, sponsored by Sanford Health.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The investigators hypothesize that multi-session anodal tDCS (atDCS) of the left dorsolateral prefrontal cortex (LDLPFC) will induce long-lasting effects in improving cognitive function and reducing cognitive fatigue and fatigability in PD patients.

Conditions Studied

Interventions

  • DEVICE transcranial direct current stimulation
  • DEVICE Sham (for transcranial direct current stimulation)

Study Locations (1)

North Dakota

  • Sanford Brain & Spine Center - Fargo

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2015-10-19
Est. Completion 2025-08-31
Phase NA

Sponsor

Sanford Health

34 total trials

What the Registry Record Tells You About NCT03191916

The ClinicalTrials.gov registry entry for NCT03191916 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The listed sponsor is Sanford Health, which has 34 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which transcranial direct current stimulation is the first listed.

NCT03191916 reports 1 study location spanning 1 distinct geographic area - top geographies include North Dakota.

Frequently Asked Questions

What is clinical trial NCT03191916 about?

NCT03191916 is a clinical study titled "Transcranial Direct Current Stimulation for Cognitive Improvement in Parkinson's Patients". The investigators hypothesize that multi-session anodal tDCS (atDCS) of the left dorsolateral prefrontal cortex (LDLPFC) will induce long-lasting effects in improving cognitive function and reducing cognitive fatigue and fatigability in PD patients.

What is the current status of trial NCT03191916?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2015-10-19. Estimated completion is 2025-08-31.

What conditions does trial NCT03191916 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT03191916?

The interventions under investigation include: transcranial direct current stimulation (DEVICE), Sham (for transcranial direct current stimulation) (DEVICE).

Who is sponsoring clinical trial NCT03191916?

This trial is sponsored by Sanford Health, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03191916 being conducted?

This trial has 1 study location across North Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.